News

New Fox Chase Attending Physician Focuses on Leukemia and Lymphoma

PHILADELPHIA (September, 2008) — Adam Cohen, MD, has joined Fox Chase Cancer Center's medical oncology staff as an attending physician.  He treats patients with cancers of the blood and bone marrow such as leukemia and lymphoma. 

Cohen has a special interest in the cancer called multiple myeloma and a rare related disorder called amyloidosis, which occurs when bone marrow produces too much of certain antibody proteins that then build up in the bloodstream and may affect various organs.

"My goal is to develop new therapies for these complicated diseases, with a focus on trying to harness the power of the immune system to attack and hopefully eliminate cancerous cells," Cohen says.

A board-certified medical oncologist, Cohen earned his MD at the University of Pennsylvania.  He comes to Fox Chase from Memorial Sloan-Kettering Cancer Center in New York, where he completed a fellowship in 2005.

---

Fox Chase Cancer Center is one of the leading freestanding cancer research and treatments centers in the United States. Founded in 1904 in Philadelphia as the nation's first cancer hospital, Fox Chase became one of the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, treatment, and community outreach. For more information, call 1-888-FOX-CHASE or 1-888-369-2427. Other 2008 releases

Media inquiries only, please contact Diana Quattrone at 215-728-7784.